The optimal pharmacological formula for percutaneous coronary intervention

Author： Capodanno Davide Tamburino Corrado Dangas George

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.7, 2011-05, pp. : 1075-1086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological antithrombotic adjuncts to percutaneous coronary intervention

By Lucking Andrew J Newby David E

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 759-776

Informa Healthcare

Access to resources Recommend Favorite

Oral antiplatelet therapy and percutaneous coronary intervention

By Yan Bryan PY Clark David J Ajani Andrew E

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 3-12

Informa Healthcare

Access to resources Recommend Favorite

A Guide to Drug Use During Percutaneous Coronary Intervention

By Choo J.K. Young J.J. Kereiakes D.J.

Drugs, Vol. 62, Iss. 18, 2002-01 ,pp. : 2589-2601

Adis International

Access to resources Recommend Favorite

Local Delivery of Therapeutics for Percutaneous Coronary Intervention

Current Drug Delivery, Vol. 8, Iss. 5, 2011-01 ,pp. : 534-556

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacoeconomics of Anticoagulants in Acute Coronary Syndrome and Percutaneous Coronary Intervention

Current Pharmaceutical Design, Vol. 14, Iss. 12, 2008-04 ,pp. : 1197-1204

Bentham Science Publishers

Access to resources Recommend Favorite